Official Section of
The International Xenotransplantation Association (IXA) would like to acknowledge the following companies and organizations for their generous contribution to our 2025 Congress.
GOLD SPONSORS
Idriz Limaj
Head of Operations
Tel: +1-617-821-4846
Xeno organs to be used for organ transplantation.
Yin Lu
Vice General Manager
Tel: +86 139 8188 9268
Clonorgan Company develops xenotransplantation donor pigs, breeding over 10 GE pig lines, achieving natural breeding and stable inheritance across generations. It built China's first DPF facility and achieved Asia's first GE pig kidney transplant into patient, with >5 months' survival.
Jennifer Bergheiser
Chief Business Officer
eGenesis, Inc. is a biotechnology company developing human-compatible engineered organs for human transplant. Our mission is to end waitlist mortality and transform the treatment of organ failure with a scalable and sustainable source of organs. eGenesis is advancing programs in kidney transplantation, acute liver failure, and heart transplantation.
David Ayares, PhD
President and CSO
Tel: +1-540-449-3873
Regenerative medicine company focused on the genetic modification of pigs for use in providing an unlimited supply of organs toward overcoming the organ shortage crisis.
We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions.
SILVER SPONSORS
Eledon is dedicated to significantly improve both the longevity of the organ and the overall health and quality of life for transplant recipients. Our lead compound is tegoprubart, an anti-CD40L antibody with broad therapeutic potential to regulate drivers that can lead to the immune system attacking and rejecting transplanted organs.
Robert Vodrazka
Commercial Manager
Tel: +41 79 155 14 20
At XVIVO, we believe in an extended life of organs, and that nobody should die waiting for a new organ. This is what drives us every day, influences how we work together and guides how we support our customers. All to give more patients the chance to receive a life-saving transplant.
BRONZE SPONSORS
At Apellis, we combine courageous science and compassion to develop life-changing medicines for some of the most challenging diseases patients face. Our goal is to transform treatment for a broad range of debilitating diseases by controlling a part of the immune system known as the complement cascade, which can damage healthy cells and tissues when overactivated. In 2021, we ushered in the first new class of complement medicine in 15 years. We now have two first-in-class medicines targeting C3 across four diseases. C3 is the central protein in the complement cascade and the only target that addresses all three pathways that can initiate and drive disease.
Andrea May (Onsite Representative)
Commercial Manager
Astellas is a global leader in transplantation, providing immunosuppressant treatments for solid organ transplants such as kidney, liver and heart. With the goal of improving patients’ quality of life, Astellas works in partnership with the transplant communities and supports various initiatives.
Robert Woodward
Chief Scientific Officer
CareDx is the leading partner in transplant care, offering a comprehensive ecosystem of solutions across the transplant journey. With deep expertise, over 190 publications, and more than 1 million tests delivered, CareDx empowers clinical decision-making, optimizes workflows, and supports patients through personalized pharmacy services and innovative diagnostics
CSL (ASX:CSL; USOTC:CSLLY) is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our three businesses, CSL Behring, CSL Seqirus and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 29,000+ people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest. For inspiring stories about the promise of biotechnology, visit CSL.com/Vita and follow us on x.com/CSL. For more information about CSL, visit CSL.com.
Marion L. Shuck
Executive Vice President, Governmental Relations and External Affairs
Tel: +1-630-758-2616
Gift of Hope coordinates organ and tissue donation in Illinois and northwest Indiana. Your decision to donate can save many lives. By joining the donor registry, you give hope to thousands of people waiting for life-saving transplants. Your choice to be a donor creates a lasting legacy, turning one person’s generosity into a second chance for others. At every step, the donation process is handled with the utmost care, compassion and attention to detail. It is a profoundly life-changing journey made possible by the selfless choice of donors. The generosity of those who donate allows us to transform countless lives, giving hope to those in need.
Mr. Daryl Poythress
Regional Director, OH Sales - Abdominal
Tel: +1-919-971-0127
Natera™ is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives.
OM Pharma is transforming immune health. By using our expertise in bacterial lysates, we address some of the most significant global health challenges.
Dr. Shigeki Toyoshima
Senior Manager
Otsuka Pharmaceutical Factory has embraced the management vision of being “The Best Partner in Clinical Nutrition Worldwide.” As the originating company of the Otsuka Group, we have been engaged in the intravenous (IV) solutions business for over 75 years, leading the development of IV solutions in Japan as a pioneering company in this field.
Ms. Tarina Espinoza
Personal Assistant
Tel: +41 58 123 80 32
Swisstransplant maintains the waiting list of organ recipients on behalf of the Federal Office of Public Health and is responsible for the allocation of organs in accordance with the law. Since 2009, the foundation has been commissioned by the Swiss Conference of Cantonal Health Directors to coordinate the cantons' tasks in the field of organ and tissue donation at national level, as laid down in the Transplantation Act, to ensure these tasks are carried out in conjunction with organ donation networks in Switzerland and abroad, and to exploit synergies.
Brian Masters
Regional Medical Liaison
Let's transform transplant medicine. Together.
EXHIBITORS & CONTRIBUTORS
Estelle Dovat
Rare Disease Partner Hematology & Nephrology
Tel: +41 79 934 62 77
As Alexion, AstraZeneca Rare Disease, we are delivering life-changing therapies to people living with rare diseases.
Now, as part of AstraZeneca, we have the potential to impact the lives of even more people around the world.
Feyyaz Artukoglu
Baskent University General Coordinator
Tel: +90 532 792 25 58
Başkent University was founded in 1993 as one of the foundation universities of Turkey. The founder and honorary president, Prof. Dr. Mehmet Haberal, performed the first successful transplantation surgery in Turkey (1975) and is renowned worldwide in the medical community.
Başkent University has a broad spectrum of faculties across all branches of science, including medicine, pharmacy, dentistry, engineering, administration, social sciences, political sciences, financial sciences, and law. Above all, the university’s main focus is medicine.
The university operates 12 hospitals, dialysis centers, and burn units throughout the country, forming an integrated medical network. In addition to its comprehensive medical departments, its scientific efforts are especially concentrated in the fields of liver, heart, and kidney transplantation, HLA typing and immunogenetics, and burn care.
Karius has pioneered liquid biopsy for infectious disease diagnostics for over a decade, with a focus on immunocompromised patients. Within that journey, Karius is committed to support the development of xenotransplantation by offering liquid biopsy diagnostic capabilities across infection, tissue injury, and immunosuppression, partnering across academia and industry.
Mr. Andy Self
SVP New Ventures
Tel: +44 1865 632051
OrganOx is a commercial stage organ technology company, dedicated to developing technologies to improve outcomes for patients with acute or chronic organ failure
Dr. David Machacek, Dr.-Ing.
Our perfusion machine decreases the price of commercial perfusion devices by a factor 10, enabling high quality cost-effective perfusion for xeno transplantation.
Fynn Comerford
At Until, we develop novel molecular agents, perfusion and surgical protocols, and cooling and rewarming hardware to support reversible cryopreservation of biological systems. Our goal is to extend organ viability beyond current limits so that every donated organ has the chance to reach a patient in need before it times out.